Johnson & Johnson Aktie
WKN: 853260 / ISIN: US4781601046
17.10.2023 12:28:37
|
Johnson & Johnson Q3 Profit Beats Estimates
(RTTNews) - Johnson & Johnson (JNJ) released a profit for third quarter that beat the Street estimates.
The company's earnings totaled $4.31 billion, or $1.69 per share. This compares with $4.31 billion, or $1.62 per share, in last year's third quarter.
Excluding items, Johnson & Johnson reported adjusted earnings of $6.78 billion or $2.66 per share for the period.
Analysts on average had expected the company to earn $2.51 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 6.8% to $21.35 billion from $20.00 billion last year.
Johnson & Johnson earnings at a glance (GAAP) :
-Earnings (Q3): $4.31 Bln. vs. $4.31 Bln. last year. -EPS (Q3): $1.69 vs. $1.62 last year. -Analyst Estimates: $2.51 -Revenue (Q3): $21.35 Bln vs. $20.00 Bln last year.
-Guidance: Full year EPS guidance: $10.07 - $10.13 Full year revenue guidance: $84.4 - $84.8 Bln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
18:01 |
Pluszeichen in New York: Dow Jones-Börsianer greifen zu (finanzen.at) | |
12:06 |
Ausblick: Johnson & Johnson gewährt Anlegern Blick in die Bücher (finanzen.net) | |
13.10.25 |
Börse New York in Grün: Dow Jones steigt (finanzen.at) | |
10.10.25 |
Minuszeichen in New York: Dow Jones präsentiert sich zum Handelsende schwächer (finanzen.at) | |
10.10.25 |
Verluste in New York: Dow Jones verbucht am Nachmittag Verluste (finanzen.at) | |
10.10.25 |
Börse New York: Dow Jones am Freitagmittag im Minus (finanzen.at) | |
09.10.25 |
Angespannte Stimmung in New York: Dow Jones fällt letztendlich zurück (finanzen.at) | |
09.10.25 |
Börse New York: Dow Jones sackt am Donnerstagnachmittag ab (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 160,98 | -2,03% |
|